advertisement
Boal AM 15
Showing records 1 to 15 | Display all abstracts from Boal AM108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Boal AM
Translational vision science & technology 2023; 12: 1
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Naguib S
Antioxidants (Basel, Switzerland) 2023; 12:
108363 Retinal ganglion cells adapt to ionic stress in experimental glaucoma
Boal AM
Frontiers in neuroscience 2023; 17: 1142668
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
DeJulius CR
Antioxidants (Basel, Switzerland) 2023; 12:
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
McGrady NR
Translational vision science & technology 2023; 12: 1
108363 Retinal ganglion cells adapt to ionic stress in experimental glaucoma
McGrady NR; Holden JM
Frontiers in neuroscience 2023; 17: 1142668
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Chamling X
Translational vision science & technology 2023; 12: 1
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Backstrom JR; Haider AA
Antioxidants (Basel, Switzerland) 2023; 12:
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Kagitapalli BS
Translational vision science & technology 2023; 12: 1
108363 Retinal ganglion cells adapt to ionic stress in experimental glaucoma
Risner ML
Frontiers in neuroscience 2023; 17: 1142668
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Zack DJ
Translational vision science & technology 2023; 12: 1
108363 Retinal ganglion cells adapt to ionic stress in experimental glaucoma
Calkins DJ
Frontiers in neuroscience 2023; 17: 1142668
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Ang JM; Boal AM
Antioxidants (Basel, Switzerland) 2023; 12:
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Calkins DJ; Risner ML
Translational vision science & technology 2023; 12: 1
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Calkins DJ; Duvall CL; Rex TS
Antioxidants (Basel, Switzerland) 2023; 12:
